US equities
|
NVDA
$183.46
▼-8.33%
MU
$675.64
▼-15.04%
TSLA
$342.74
▼-11.02%
AMD
$414.18
▼-15.26%
SNDK
$831.85
▼-19.81%
SPCX
$125.39
▼-7.75%
AAPL
$345.01
▼-1.29%
AMZN
$259.44
▼-2.48%
NVDA
$183.46
▼-8.33%
MU
$675.64
▼-15.04%
TSLA
$342.74
▼-11.02%
AMD
$414.18
▼-15.26%
SNDK
$831.85
▼-19.81%
SPCX
$125.39
▼-7.75%
AAPL
$345.01
▼-1.29%
AMZN
$259.44
▼-2.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Verastem, Inc.
Verastem Oncology to Present at the 2021 Jefferies Virtual Healthcare Conference
May 25, 2021
From
Verastem, Inc.
Via
Business Wire
Tickers
VSTM
Verastem Oncology Receives Breakthrough Therapy Designation for VS-6766 with Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
May 24, 2021
From
Verastem, Inc.
Via
Business Wire
Tickers
VSTM
